Krishna Institute of Medical Sciences Ltd

Krishna Institu. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Krishna Institute of Medical Sciences Ltd

₹ 1,530 -1.95%
05 Jun 4:01 p.m.
kimshospitals.com BSE: 543308 NSE : KIMS
About

Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.

Key Points

Regional Leadership
KIMS is one of the largest corporate healthcare groups in Andhra Pradesh (AP) and Telangana in terms of the number of patients treated and treatments offered. It provides multidisciplinary integrated healthcare services, with a focus on primary, secondary & tertiary care in tier 2-3 cities and primary, secondary, tertiary, and quaternary healthcare in tier 1 cities. [1]

Website BSE NSE
  • Market Cap ₹ 12,244 Cr.
  • Current Price ₹ 1,530
  • High / Low ₹ 1,669 / 1,113
  • Stock P/E 48.5
  • Book Value ₹ 204
  • Dividend Yield 0.00 %
  • ROCE 22.3 %
  • ROE 16.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 38.6% CAGR over last 5 years

Cons

  • Stock is trading at 7.76 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 31.7 to 38.7 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
140 282 254 257 332 284 273 254 263 292 284 293
106 175 175 172 220 186 174 166 185 204 194 189
Operating Profit 34 107 79 84 111 98 99 88 78 88 90 104
OPM % 24% 38% 31% 33% 34% 35% 36% 35% 30% 30% 32% 36%
4 2 0 4 4 9 3 8 4 8 7 5
Interest 5 3 4 3 2 1 1 1 0 0 0 0
Depreciation 10 11 13 11 11 11 11 11 11 11 11 11
Profit before tax 23 95 62 74 102 95 90 84 70 84 86 98
Tax % 25% 26% 23% 29% 25% 25% 25% 24% 26% 27% 25% 24%
Net Profit 17 71 48 53 76 71 67 64 52 61 64 75
EPS in Rs 2.28 9.53 6.38 6.84 9.52 8.91 8.37 7.99 6.51 7.65 8.06 9.33
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
485 536 628 707 790 933 1,143 1,132
380 422 562 652 584 624 740 772
Operating Profit 104 114 66 55 206 309 403 360
OPM % 22% 21% 10% 8% 26% 33% 35% 32%
4 3 3 6 7 8 21 24
Interest 36 32 88 33 24 18 9 1
Depreciation 34 34 38 41 43 45 45 45
Profit before tax 38 51 -57 -13 147 254 371 337
Tax % 37% 37% -43% -225% 17% 26% 25% 25%
Net Profit 24 33 -81 -44 121 189 278 252
EPS in Rs 3.45 4.54 -11.35 -5.86 16.26 24.31 34.78 31.55
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 13%
3 Years: 13%
TTM: -1%
Compounded Profit Growth
10 Years: %
5 Years: 39%
3 Years: 28%
TTM: -10%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 25%
Return on Equity
10 Years: %
5 Years: 19%
3 Years: 21%
Last Year: 17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
70 72 50 74 74 78 80 80
Reserves 191 252 -249 429 549 830 1,298 1,551
251 277 666 187 186 131 18 4
134 153 323 166 148 175 173 177
Total Liabilities 646 753 789 857 957 1,214 1,569 1,812
498 501 576 567 559 582 592 612
CWIP 2 64 0 0 2 8 13 16
Investments 18 22 31 80 178 213 542 785
128 167 182 210 218 411 422 399
Total Assets 646 753 789 857 957 1,214 1,569 1,812

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
89 78 94 109 161 291 284 270
-39 -99 -52 -99 -108 -317 -375 -237
-61 25 -42 -12 -24 25 76 -15
Net Cash Flow -10 5 0 -2 28 0 -15 18

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 46 59 56 52 46 29 28 39
Inventory Days 35 43 39 42 44 30 38 30
Days Payable 192 205 189 161 158 155 118 112
Cash Conversion Cycle -111 -103 -94 -68 -68 -96 -52 -44
Working Capital Days 11 26 -72 7 -2 -4 10 26
ROCE % 15% 6% 3% 23% 30% 31% 22%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
38.84 38.84 38.84 38.84 38.84 38.85 38.85 38.85
11.57 9.90 8.44 8.91 8.36 10.17 20.50 19.41
16.28 18.64 20.87 21.02 22.78 27.97 28.32 29.76
33.31 32.61 31.84 31.23 30.01 23.01 12.34 11.99

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls